QWB
- Product code
- QWB
- Device name
- Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3984
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 2
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 3 (all years; only the last 3 years are listed here)
FDA classification definition
An over-the-counter molecular test to detect SARS-CoV-2 is an in vitro diagnostic device for the detection of SARS-CoV-2 in clinical specimens to aid in the diagnosis of SARS-CoV-2 infection. The device is intended to be used by lay users and without health care provider (HCP) intervention in home settings or similar environments.
510(k) clearances, last 3 years (2)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K253453 | 2026-08-07 | Aptitude Medical Systems, Inc. | Metrix COVID Test; Metrix COVID Test Pro | |
| K232643 | 2023-11-28 | Cue Health, Inc. | Cue COVID-19 Molecular Test | FDA |
Official FDA classification page: QWB
Classification and pathway per current FDA publications. Data from openFDA (CC0).